Terns Pharmaceuticals, Inc.

Nasdaq:TERN

Pharmaceutical Preparations·FOSTER CITY, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/5/24	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
1/9/26	Q4 FY2026	→
11/10/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

38 shown

Filed	Type	Description
3/25/26	Agreement	Entry into a Material Definitive Agreement	→
1/22/26	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Other	Other Events	→
12/8/25	Reg FD	Regulation FD Disclosure	→
11/3/25	Reg FD	Regulation FD Disclosure	→
10/22/25	Other	Other Events	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
12/11/25	424B5	424B5	→
12/9/25	424B5	424B5	→
12/9/25	S-3ASR	S-3ASR	→
5/8/25	S-3	S-3	→
4/29/25	ARS	ARS	→
3/20/25	S-8	S-8	→
↓

Filing History(398 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Mar 27, 2026

0000102909-26-002421

—

7.0 KB

SC TO-C

Mar 26, 2026

0001193125-26-124741SC TO-C

—

123.1 KB

SC14D9C

Mar 25, 2026

0001193125-26-124334SC14D9C

—

176.0 KB

SC TO-C

Mar 25, 2026

0001193125-26-124269SC TO-C

—

7.1 MB

SC14D9C

Mar 25, 2026

0001193125-26-122823SC14D9C

—

42.4 KB

SC TO-C

Mar 25, 2026

0001193125-26-122803SC TO-C

—

82.5 KB

8-K

Mar 25, 2026

0001193125-26-1227858-K

Mar 24, 2026

787.8 KB

Mar 17, 2026

0001872564-26-000008PRIMARY DOCUMENT

Mar 16, 2026

12.1 KB

Feb 18, 2026

0001872564-26-000006PRIMARY DOCUMENT

Feb 17, 2026

14.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001831942-26-000009

—

15.2 KB

SCHEDULE 13G/A

Feb 13, 2026

0001213900-26-016651

—

20.4 KB

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000722

—

11.8 KB

SCHEDULE 13G/A

Feb 12, 2026

0001213900-26-015655

—

19.2 KB

SCHEDULE 13G

Feb 12, 2026

0000902664-26-000916

—

16.0 KB

Feb 2, 2026

0001403571-26-000002PRIMARY DOCUMENT

Feb 1, 2026

5.8 KB

Feb 2, 2026

0001761114-26-000002PRIMARY DOCUMENT

Feb 1, 2026

5.8 KB

Feb 2, 2026

0001656998-26-000002PRIMARY DOCUMENT

Feb 1, 2026

5.8 KB

Feb 2, 2026

0001799780-26-000002PRIMARY DOCUMENT

Feb 1, 2026

5.8 KB

Feb 2, 2026

0001174454-26-000003PRIMARY DOCUMENT

Feb 1, 2026

6.0 KB

Feb 2, 2026

0001041126-26-000002PRIMARY DOCUMENT

Feb 1, 2026

5.8 KB

8-K

Jan 22, 2026

0001193125-26-0194268-K

Jan 16, 2026

140.1 KB

Jan 16, 2026

0001892413-26-000004PRIMARY DOCUMENT

Jan 14, 2026

7.6 KB

Jan 16, 2026

0001563623-26-000002PRIMARY DOCUMENT

Jan 14, 2026

7.8 KB

Jan 16, 2026

0001872564-26-000004PRIMARY DOCUMENT

Jan 14, 2026

23.7 KB

144

Jan 15, 2026

0001950047-26-000467

—

5.6 KB

25 filings shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
4/25/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Terns Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(398 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/17/26	4	PRIMARY DOCUMENT	→
2/18/26	4	PRIMARY DOCUMENT	→
2/2/26	4	PRIMARY DOCUMENT	→
2/2/26	4	PRIMARY DOCUMENT	→
2/2/26	4	PRIMARY DOCUMENT	→
2/2/26	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
3/27/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/26/26	SC TO-C	SC TO-C	→
3/25/26	SC14D9C	SC14D9C	→
3/25/26	SC TO-C	SC TO-C	→
3/25/26	SC14D9C	SC14D9C	→
3/25/26	SC TO-C	SC TO-C	→
↓